Real-World Evaluation of the Efficacy of Third-Line Treatment Regimens for Advanced Gastric Cancer: A Single-Center Retrospective Study

Key Points

• To evaluate the effectiveness of third-line treatment regimens for patients with advanced gastric cancer.
• Conducted a single-center retrospective study
• Analyzed patient outcomes on third-line chemotherapy
• Compared efficacy of chemotherapy combined with immune and targeted therapies
• Patients showed the longest median survival time with third-line combined regimens
• Higher incidence of adverse events was reported with these treatments
• Total treatment costs increased significantly for patients receiving combined therapy